Effect of interleukin-1 blockers, CK112, and CK116 on rat experimental choroidal neovascularization in vivo and endothelial cell cultures in vitro

Journal of Ocular Pharmacology and Therapeutics

Volumn 22, Issue 1, 2006, Pages 19-25

  Zou, Yanhong ^a   Xu, Xinrong ^a   Chiou, George C Y ^a,b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANECORTAVE; CK 112; CK 116; DEXAMETHASONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PREDNISOLONE; STEROID; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRUCH MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; ENDOTHELIUM CELL; FLUORESCENCE ANGIOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NEODYMIUM LASER; NONHUMAN; RAT; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL PROLIFERATION; CELLS, CULTURED; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-1; MALE; PREDNISOLONE; PYRIDAZINES; RATS; RATS, INBRED BN; UMBILICAL VEINS;

EID: 33644842006     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.22.19     Document Type: Article

References (21)

1. The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 122:477-485, 2004.
2. Klein, R., Klein, B.E., and Linton, K.L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99:933-943, 1992.
3. Zou, Y.H., and Chiou, G.C. Pharmacological therapy in age-related macular degeneration (ARMD). Int. J. Ophthalmol. 5:8-18, 2005.
4. Espinosa-Heidmann, D.G., Suner, I.J., Hernandez, E.P., et al. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44:3586-3592, 2003.
5. Sakurai, E., Arand, A., Ambati, B.K., et al. Macrophage depletion inhibits experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44:3578-3585, 2003.
6. Kent, D., and Sheridan, C. Choroidal neovascularization: A wound-healing perspective. Mol. Vis. 9:747-755, 2003.
7. Ambati, J., Ambati, B.K., Yoo, S.H., et al. Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol. 48:257-293, 2003.
8. Chiou, G.C. Review: Effects of nitric oxide on eye disease and their treatment. J. Ocul. Pharmacol. Ther. 17(2):189-198, 2001.
9. Yamasaki, T., Kawaminami, E., Yamada, T., et al. Novel heterocyclization of hydrazinopyridazinones with dimethyl acetylene dicarboxylate with dehydrogenation and rearrangement. J. Chem. Soc. Perkin Trans. 1:991-996, 1991.
10. Yamasaki, T., Yoshihara, Y., Okamoto, Y., et al. A new approach to the synthesis of pyridazino[4,5-c]pyridazinones. J. Hetero. Chem. 29:1313-1316, 1992.
11. Yamasaki, T., Yoshihara, Y., Okamoto, Y., et al. One-pot synthesis of new spiro- and tricyclic pyridazino [4,5-c]pyridazinones. Heterocycles 43:1613-1620, 1996.
12. Chiou, G.C., Yao, Q.S., and Okawara, T. Prevention of ocular inflammation induced by lens protein, endotoxin, and interleukin-1 with synthetic interleukin-1 blockers. J. Ocul. Pharmacol. Ther. 10:577-586, 1994.
13. Chiou, G.C., Chen, Z., Xuan, B., et al. Antagonism of interleukin-1 (IL-1)-induced uveitis with synthetic IL-1 blockers. J. Ocul. Pharmacol. Ther. 13:427-433, 1997.
14. Xuan, B., Chiou, G.C., Chen, Z., et al. Effective treatment of experimental uveitis with interleukin-1 blockers, CK 123, and CK 124. J. Ocul. Pharmacol. Ther. 14:31-44, 1998.
15. Liu, Q., Zhou, Y.H., Xuan, B., et al. Effects of interleukin-1 blockers on corneal fibroblast proliferation in vitro and ocular inflammation in vivo. J. Ocul. Pharmacol. Ther. 16:81-96, 2000.
16. Schwade, N.D., and Chiou, G.C. Effects of interleukin-1 blockers on ophthalmic wound healing in a rabbit model of trabeculectomy. J. Ocul. Pharmacol. Ther. 11:125-134, 1995.
17. Chen, Z., Liu, S.X., and Chiou, G.C. Inhibitory effects of interleukin-1 blockers on corneal fibroblast proliferation. J. Ocul. Pharmacol. Ther. 12:169-182, 1996.
18. Xiao, J.G., Schwade, N.D., and Chiou, G.C. Mechanisms of antagonism of interleukin-1 alpha by synthetic interleukin-1 blockers. J. Ocul. Pharmacol. Ther. 11:369-378, 1995.
19. Oh, H., Takagi, H., Talagi, C., et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci. 40:1891-1898, 1999.
20. Naldini, A., and Carraro, F. Role of inflammatory mediators in angiogenesis. Curr. Drug Targets Inflamm. Allergy 4:3-8, 2005.
21. Kuwano, T., Nakao, S., Yamamoto, H., et al. Cyclooxygenase-2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J. 18:300-310, 2004.